date:Jun 08, 2012
ed market or other special circumstance. In GenVec's case, the special circumstance was the need for an FMD vaccine that was capable of being manufactured in the US that allowed for the differentiation between infected and vaccinated animals. The vaccine will now be available in the event of an FMD emergency situation, GenVec said.
GenVec also announced that Merial, the animal health division of Sanofi, has the rights to develop and commercialize GenVec's FMD vaccine for use in cattle.